Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Aulitzky

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Current Problems in Dermatology|January 1, 1989
Clinical signs of immunodeficiencyC Huber, W E Aulitzky
Der Urologe. Ausg. A|June 8, 2004
[Immunotherapy for advanced renal cell carcinoma]W E Aulitzky, M Kaufmann
International Archives of Allergy and Immunology|January 1, 1993
Cytokine therapy of neoplastic and inflammatory diseaseW E Aulitzky, C Huber, C Peschel
Leukemia & Lymphoma|September 1, 1996
Influence of interferon-alpha on cytokine expression by the bone marrow microenvironment--impact on treatment of myeloproliferative disordersC Peschel, W E Aulitzky, C Huber
Presse Medicale (Paris, France : 1983)|June 18, 1994
Clinical applications of cytokinesC Peschel, C Huber, W E Aulitzky
Annals of Hematology|July 11, 2002
Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantationM Henkes, S Martin, H Einsele, et al.
Annals of Hematology|March 1, 1995
Biotherapy of chronic myelogenous leukemiaW E Aulitzky, C Peschel, F Schneller, et al.
Deutsche Medizinische Wochenschrift (1946)|May 3, 1996
[Chronic myeloproliferative diseases. New knowledge about well known diseases]W E Aulitzky, M Griesshammer, H Heimpel, et al.
Drugs|November 1, 1994
Interleukins. Clinical pharmacology and therapeutic useW E Aulitzky, M Schuler, C Peschel, et al.
Experimental Hematology|December 1, 1995
Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitorsD Després, J Goldschmitt, W E Aulitzky, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Current Problems in Dermatology|January 1, 1989
Clinical signs of immunodeficiencyC Huber, W E Aulitzky
Der Urologe. Ausg. A|June 8, 2004
[Immunotherapy for advanced renal cell carcinoma]W E Aulitzky, M Kaufmann
International Archives of Allergy and Immunology|January 1, 1993
Cytokine therapy of neoplastic and inflammatory diseaseW E Aulitzky, C Huber, C Peschel
Leukemia & Lymphoma|September 1, 1996
Influence of interferon-alpha on cytokine expression by the bone marrow microenvironment--impact on treatment of myeloproliferative disordersC Peschel, W E Aulitzky, C Huber
Presse Medicale (Paris, France : 1983)|June 18, 1994
Clinical applications of cytokinesC Peschel, C Huber, W E Aulitzky
Annals of Hematology|July 11, 2002
Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantationM Henkes, S Martin, H Einsele, et al.
Annals of Hematology|March 1, 1995
Biotherapy of chronic myelogenous leukemiaW E Aulitzky, C Peschel, F Schneller, et al.
Deutsche Medizinische Wochenschrift (1946)|May 3, 1996
[Chronic myeloproliferative diseases. New knowledge about well known diseases]W E Aulitzky, M Griesshammer, H Heimpel, et al.
Drugs|November 1, 1994
Interleukins. Clinical pharmacology and therapeutic useW E Aulitzky, M Schuler, C Peschel, et al.
Experimental Hematology|December 1, 1995
Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitorsD Després, J Goldschmitt, W E Aulitzky, et al.
Pageof 9